Please assess the completion status of the following clinical trial:

Trial Title: Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients with locally advanced, metastatic or recurrent pancreatic ductal adenocarcinoma (PDAC)~2. Patients who are being treated and/or followed at Indiana University Simon Cancer Center or Eskenazi Hospital~3. ECOG PS 0-2 at the time of study enrollment~4. Life expectancy \> 6 months~5. Adequate organ function~   * As defined by the following laboratory values at study entry:~  * Hemoglobin ≥ 9 g/dL (transfusions are acceptable)~  * ANC ≥ 1.5 x 109/L~  * Platelets ≥ 100 x 109/L~  * Creatinine ≤ 1.5 x ULN, or creatinine clearance ≥ 50 mL/min (estimated by Cockcroft-Gault or measured)~  * Total bilirubin ≤ 1.5 x ULN~  * AST/ALT ≤ 3 x ULN~6. Willingness to sign informed consent and to perform pulmonary function tests (PFTs) and strain echocardiogram~Exclusion Criteria:~1. Known history of congestive heart failure (NYHA class III or IV)~2. Reported weight loss more than 10% within 3 months prior to study entry~3. Known history of pulmonary disease such as pulmonary hypertension, chronic obstructive pulmonary disease requiring medical management or previous lung resection~4. Current liver cirrhosis~5. Current chronic kidney disease~6. Inability or refusal to receive systemic therapy~7. Inability to comply with pulmonary function tests (PFTs)~8. Large volume ascites interfering with ability of respiration~9. Current unstable angina (or history of within last 6 months)~10. Recent myocardial infraction (within last 6 months)~11. Recent pneumothorax (within last 6 months)~12. Uncontrolled hypertension (per investigator's discretion)~13. Lung biopsy within one week from PFT~14. Recent surgery \< 4 weeks

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).